Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
about
Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependenceNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Cognitive enhancers in the treatment of substance use disorders: clinical evidence.Off-label use of atomoxetine in adults: is it safe?ADHD medication reduces cotinine levels and withdrawal in smokers with ADHDOptimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.Withdrawal From Chronic Nicotine Reduces Thyroid Hormone Levels and Levothyroxine Treatment Ameliorates Nicotine Withdrawal-Induced Deficits in Hippocampus-Dependent Learning in C57BL/6J Mice.Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers.Issues related to implementing a smoking cessation clinical trial for cancer patients.Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment.Transdisciplinary Tobacco Use Research Centers: research achievements and future implications.Tobacco smoking in individuals with attention-deficit hyperactivity disorder: epidemiology and pharmacological approaches to cessation.The effects of acute nicotine, chronic nicotine, and withdrawal from chronic nicotine on performance of a cued appetitive response.Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.
P2860
Q26999258-FB85A9F6-AC0F-461F-ABFC-CD15E9A4BC5DQ28277165-107A7DAD-7ED2-4A2B-9AE7-9C4CDE1CB6CEQ34183988-C23C0FEC-84C1-4233-833D-D9DDB600821FQ34618993-11021788-BD88-423B-8221-312A552B4655Q34729003-61CE7C82-101B-4133-A4FD-0BC5F9A410C8Q34870758-84BF6131-68DA-44B9-AA4A-D008A52D13B5Q35785041-B840EA58-2FC5-4DCC-982F-1EF543C8A0C1Q35893802-A7A2B5F9-7DFE-4274-BDA5-96365DC53B74Q37066344-4CF1C74A-0C54-4577-8563-4559B3C20EBEQ37188764-FE349FC4-0F7F-45BA-97E7-C713839D3D16Q37353353-15003C56-2B4E-4D99-B435-E4C5C237CCD2Q37435567-70AED3CD-EC85-4C7C-9F49-EF8F34769BAFQ37706033-7C137074-159C-41E4-A5BB-0447C6764401Q38065287-7A3746D6-860F-4E4D-A1C3-E060AC7265EA
P2860
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
@en
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
@nl
type
label
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
@en
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
@nl
prefLabel
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
@en
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
@nl
P2093
P2860
P356
P1476
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
@en
P2093
Aa Strasser
F Patterson
M Rukstalis
P2860
P304
P356
10.1177/0269881108089580
P407
P577
2008-05-30T00:00:00Z